Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2011-07-05
2011-07-05
Canella, Karen A (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S374000, C436S064000
Reexamination Certificate
active
07972769
ABSTRACT:
An improved method for preparing a cell culture is disclosed. The method includes culturing a multicellular tissue explant in the presence of growth medium that is substantially free of enzymes capable of digesting the explant and, subsequently, removing the explant at a predetermined time.
REFERENCES:
patent: 4423145 (1983-12-01), Stampfer et al.
patent: 4559299 (1985-12-01), Rotman
patent: 4668618 (1987-05-01), Thornthwaite
patent: 4816395 (1989-03-01), Hancock et al.
patent: 4937187 (1990-06-01), Rotman
patent: 4996145 (1991-02-01), Weisenthal
patent: 5242806 (1993-09-01), Yen-Maguire et al.
patent: 5270172 (1993-12-01), Morgan
patent: 5403574 (1995-04-01), Piwnica-Worms
patent: 5443950 (1995-08-01), Naughton et al.
patent: 5585265 (1996-12-01), Kahn et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5705270 (1998-01-01), Soon-Shiong et al.
patent: 5728541 (1998-03-01), Kornblith
patent: 5789158 (1998-08-01), Knowles et al.
patent: 5874218 (1999-02-01), Drolet
patent: 5888765 (1999-03-01), Patterson et al.
patent: 5942385 (1999-08-01), Hirth
patent: 5972639 (1999-10-01), Parandoosh
patent: 6008007 (1999-12-01), Fruehauf et al.
patent: 6020473 (2000-02-01), Keyt et al.
patent: 6111092 (2000-08-01), Williamson
patent: 6261795 (2001-07-01), Fruehauf et al.
patent: 6303324 (2001-10-01), Fruehauf
patent: 6335170 (2002-01-01), Orntoft
patent: 6416967 (2002-07-01), Kornblith
patent: 6511806 (2003-01-01), Fruehauf et al.
patent: 6664062 (2003-12-01), Stanton, Jr.
patent: 6887680 (2005-05-01), Kornblith
patent: 6900027 (2005-05-01), Kornblith
patent: 6933129 (2005-08-01), Kornblith
patent: 7112415 (2006-09-01), Kornblith
patent: 7314731 (2008-01-01), Kornblith
patent: 7563593 (2009-07-01), Kornblith
patent: 7575868 (2009-08-01), Kornblith et al.
patent: 7829288 (2010-11-01), Kornblith et al.
patent: 2002/0168679 (2002-11-01), Naus et al.
patent: 2002/0177147 (2002-11-01), Mealey et al.
patent: 2003/0096290 (2003-05-01), Fruehauf et al.
patent: 2003/0148345 (2003-08-01), Kopreski
patent: 2004/0023375 (2004-02-01), Kornblith et al.
patent: 2004/0072772 (2004-04-01), Kornblith et al.
patent: 2004/0086888 (2004-05-01), Kornblith et al.
patent: 2005/0004766 (2005-01-01), Ramnarayan et al.
patent: 0911389 (1999-04-01), None
patent: WO 98/02038 (1998-01-01), None
patent: WO 00/75287 (2000-12-01), None
patent: WO 01/65994 (2001-09-01), None
patent: WO 01/79540 (2001-10-01), None
patent: WO 02/33117 (2002-04-01), None
patent: WO 2004/015065 (2004-02-01), None
patent: WO 2004/035833 (2004-04-01), None
Freshney (The Culture of Animal Cells, 1994, pp. 292-296, 299, 351-352).
Ness et al., Cell viability assay for drug testing in ovarian cancer: In vitro kill versus clinical response, Anticancer Research, 22(2B), pp. 1145-1149, (Mar. 2002), XP009082283.
Mothersill et al., Effect of radiation and other cytotoxic agents on the growth of cells cultured from normal and tumor tissues from the female genital tract, Gynecologic Oncology, 37(2), pp. 210-218, (1990), XP002429819.
Jung et al., A three-dimensional micro-organ culture system optimized for in vitro growth of human malignant brain tumors, Neurosurgery, 29(3), (1991), XP001055649.
Letwin, Chemosensitivity testing, Clinical Journal of Oncology Nursing, 5(5), pp. 195-200, (Sep. 2001), XP009082265.
Ochs et al., Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors, In Vitro Cellular and Developmental Biology—Animal, 39(1-2), pp. 63-70, (2003), XP009082263.
Supplementary European Search Report based on International Appl. No. PCT/US2003/023888, (May 8, 2007).
PL Kornblith et al., “Response variability of human brain tumors to AZQ in tissue culture,” Journal of Neuro-Onocology, 1986, pp. 49-54, vol. 4, Martinus Nijhoff Publishers, Boston.
RS Weinstein et al., “Ultrastructure of a cloned astrocytoma in tissue culture,” Cancer, 1971, pp. 1174-1181, vol. 27.
PMcL Black et al., “Ultrastructural and electrophysiological features of meningioma whorls in tissue culture,” Acta Neuropathol (Berl), 1979, vol. 46, pp. 33-38.
RM Scott et al., “Invasiveness in tissue culture: A technique for study of gliomas,” Surg Forum, 1978, pp. 531-533, vol. 29.
T. Liszczak et al., “Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas,” Acta Neuropathol (Berl), 1978, pp. 191-203, vol. 43.
PL Kornblith et al., “Growth-inhibitory effects of diphenylhydantoin on human brain tumor cells in culture,” Neurosurgery, 1978, pp. 122-127, vol. 2.
RR Weichselbaum et al., “Characterization and radiobiologic parameters of medulloblastoma in vitro,” Cancer, 1977, pp. 1087-1096, vol. 40.
RL Martuza et al., “Characteristics of human optic gliomas in tissue culture,” J. Neurosurg, 1977, pp. 78-84, vol. 46.
MA Oberc-Greenwood, et al., “Ultrastructural features of the lymphocyte-stimulated halos produced by human glioma-derived derived cells in vitro,” Journal of Neuro-Oncology, 1986, pp. 387-396, vol. 3.
BH Smith et al., “Membrane and cytoplasmic changes in 1,3-bis (2-chloroethy 1)- 1—nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines,” Journal of Neuro-Oncology, 1983, pp. 237-248, vol. 1.
GA Curt et al., “Phase II and pharmacokinetic study of aziridinyl-benzoquinone (2,5-diaziridinyl-3, 6-bis(carboethoxyamino)-1,4 benzoquinone, diaziquone, NSC 182986) in high grade gliomas,” Cancer Research, 1983, pp. 6102-6105, vol. 43, Issue 12 pt 1.
N Shitara et al., “Flowcytometric and cytogenetic analysis of human cultured cell lines derived from high- and low-grade astrocytomas,” Acta Neuropathol (Berl), 1983, pp. 40-48, vol. 60.
MK Gumerlock et al., “Chemical differentiation of cultured human glioma cells: Morphologic and immunologic effects,” Surgical Forum, 1981, pp. 475-477, vol. XXXII.
PL Kornblith et al., “Growth-inhibitory effect of diphenylhydantoin on murine astrocytomas,” Neurosurgery, 1979, pp. 259-263, vol. 5.
MC Trachtenberg et al., “Biophysical properties of cultured human glial cells,” Brain Research, 1972, pp. 279-298, vol. 38.
J. Lightbody et al., “Biochemically differentiated clonal human glial cells in tissue culture,” J. Neurobiology, 1970, pp. 411-417, vol. 1, No. 4.
PMcL Black et al., “Biophysical properties of human astrocytic brain tumor cells in cell nature,” Journal of Cellular Physiology, 1980, pp. 565-570, vol. 105.
TM Liszczak et al., “Ultrastructure of human endometrial epithelium in monolayer culture with and without steroid hormones,” In Vitro, 1977, pp. 344-356, vol. 13, No. 6.
TM Liszczak et al., “Procedure for the embedment and ultrastructural visualization of cells cultured on plastic microtest plates,” Journal of Immunological Methods, 1977, pp. 131-134, vol. 15.
RM Stewart et al., “Glutamate accumulation by human gliomas and meningiomas in tissue culture,” Brain Research, 1976, pp. 441-452, vol. 118.
PL Kornblith et al., “The future of therapy for glioblastoma,” Surg Neurol, 1993, pp. 538-543, vol. 39.
PL Kornblith, “Management of malignant gliomas,” Neurosurgery Quarterly, 1991, pp. 97-110, vol. 1, Issue 2.
PL Kornblith et al., “Chemotherapy for malignant gliomas,” Journal of Neurosurgery, 1988, pp. 1-17, vol. 68, Issue 1.
PE McKeever et al., “Products of cells cultured from gliomas: VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas,” American Journal of Pathology, 1987, pp. 358-372, vol. 127, Issue 2.
PMcL Black et al., “Immunological, biological, ultrastructural, and electrophysiological characteristics of a human glioblastoma-derived cell culture line,” J. Neurosurg., 1982, pp. 62-72, vol. 56.
PL Kornblith, “The role of cytotoxic c
Gimigliano Sheri
Kornblith Paul L.
Canella Karen A
Cooley LLP
Precision Therapeutics, Inc.
LandOfFree
Method for preparing cell cultures from biological specimens... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preparing cell cultures from biological specimens..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing cell cultures from biological specimens... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719820